Duke, NEJM Study Renews Debate on Global Outsourcing
February 19, 2009 – 1:29 pm | 0 views
The ethics and safety behind the global outsourcing of clinical trials is once again being debated, with the release of a new study reporting that US drug developers conduct most of their late-stage drug trials outside of the United …
Original post by CenterWatch Editorial